anti-glutathione s-transferase omega-2 antibody

anti-glutathione s-transferase omega-2 antibody Mechanistic evaluation and transcriptional signature of a glutathione omega 1 inhibitor Mouse monoclonal has been used in Sigma-Aldrich Anti-Glutathione-S-Transferase (GST) antibody, Mouse

Name: anti-glutathione s-transferase omega-2 antibody Mechanistic evaluation and transcriptional signature of a glutathione omega 1 inhibitor Mouse monoclonal has been used in Sigma-Aldrich Anti-Glutathione-S-Transferase (GST) antibody, Mouse
Brand: vanierexcavation.com
SKU: 81710154634
Price: 25.84 USD
Availability: InStock
Rating: 4.3573 (29 reviews)

Sigma Aldrich Anti Glutathione S Transferase (GST) antibody, Mouse monoclonal, clone GST 2, purified from hybridoma cell culture 100 uL The role of glutathione S transferase in anti cancer drug resistance PMC Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect Glutathione S Transferase (GST) monoclonal antibody Western, ELISA G1160 In Vivo Characterization of the Anti Glutathione S Transferase Antibody Using an In Vitro Mite Feeding Model

SKU: 81710154634 · From vanierexcavation.com

4.4

USD25.84 USD68.84

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 14 - Oct 19

Description

Magnesium citrate, MSM (methylsulfonylmethane), coating agent: Hydroxypropylmethylcellulose, L-ascorbic acid, L-glutathione, R-alpha lipoic acid, vitamin E (tocopherol-tocotrienol complex), vitamin B6 (pyridoxine-5-phosphate), zinc gluconate, vitamin B2 (riboflavin-5-phosphate), selenomethionine, vitamin B1 (thiamine), manganese gluconate, vitamin B12 (methylcobalamin), folic acid (Quatrefolic) Food supplement: Do not exceed the recommended daily intake stated

Remarkably, metformin demonstrated immunomodulatory features in pathological contexts, including cancer, hyper-inflammatory diseases, and infectious disease, and its potential use for other medical conditions is currently being investigated in many clinical trials (Foretz et al., 2023)

Several natural compounds reduce A toxicity by inhibiting its aggregation, promoting its clearance via autophagy, and limiting synaptic dysfunction (Zeng et al., 2019)